ACCC is hosting three workshop opportunities through the Best Practices for Implementing Cancer Immunotherapy education program.
These workshops will provide guidance on key issues related to the optimal integration of cancer immunotherapies. Expert faculty will discuss the latest clinical data for immunotherapy utilization in non-small cell lung cancer (NSCLC), urothelial carcinoma, and melanoma. Workshop participants—including oncologists, oncology nurse practitioners, physician assistants, nurses, and other allied healthcare professionals—will learn about coordination and communication within the multidisciplinary care team, coverage, access, and reimbursement barriers and effective solutions, and patient education and engagement. Results will be published in Oncology Issues in 2021.
If you have any questions about this project, please contact Christina Mangir, MS, Program Manager, ACCC Provider Education.
This activity is supported by educational grants from
AstraZeneca Pharmaceuticals LP, and Merck & Co., Inc.